BIORA THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Biora Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Biora Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $1.57M, a 21.9% decline year-over-year.
  • Biora Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $15.2M, a 74.5% increase year-over-year.
  • Biora Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $16.5M, a 111% increase from 2022.
  • Biora Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $7.8M, a 42.4% decline from 2021.
  • Biora Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $13.6M, a 27.1% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $16.5M +$8.67M +111% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $7.8M -$5.75M -42.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $13.6M +$2.89M +27.1% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $10.7M +$8.29M +349% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $2.38M Jan 1, 2019 Dec 31, 2019 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.